MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...
Abstract: This article presents an improved reduced-sensor-based optimal switching sequence model predictive current control (OSS-MPCC) algorithm for a grid-tied inverter with the LCL filter with only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback